-
1by Bonter, Katherine Desjardins, Clarissa Currier, Nathan Pun, Jason Ashbury, Fredrick D Published in BMJ open (20110000)“...IntroductionIn order to provide baseline data on genetic testing as a key element of personalised medicine (PM), Canadian physicians were surveyed to determine...”
-
2by Bubela, Tania Bonter, Katherine Lachance, Silvy Delisle, Jean-Sébastien Gold, E Richard Published in Frontiers in medicine (2017-00-00)“...Cellular immunotherapies promise to transform cancer care. However, they must overcome serious challenges, including: (1) the need to identify and characterize...”
-
3by Bonter, Katherine L De Luca, Carmela Guerrini, Christi J Published in Molecular diagnosis & therapy (13.12.2017)“...In 2016, the Children's Hospital of Eastern Ontario (CHEO) announced the settlement of its patent lawsuit against US-based Transgenomic, Inc. At issue in the...”
-
4by Bonter, Katherine Breckenridge, Zackariah Lachance, Silvy Delisle, Jean-Sébastien Bubela, Tania Published in Regenerative medicine (01.09.2017)“...Global investments in cellular immunotherapies reflect their curative potential. Our landscape of clinical trials will aid developers, investors, adopters and...”
-
5by Bonter, Katherine J De Luca, Carmela Guerrini, Christi J Published in Molecular diagnosis & therapy (01.04.2018)“...An error was subsequently identified in the article, and the following correction should be noted...”
-
6by Bonter, Katherine J De Luca, Carmela Guerrini, Christi J Published in Molecular diagnosis & therapy (19.01.2018)“...An error was subsequently identified in the article, and the following correction should be noted...”
-
7by Lekpor, Kossi Benoit, Marie‐Josée Butler, Heather Schirm, Michael Vasilescu, Daniela Bonter, Katherine Chelsky, Daniel Hugo, Patrice Hunter, Joanna Opiteck, Gregory Paramithiotis, Eustache Kearney, Paul Published in Proteomics. Clinical applications (05.05.2007)“...Multidimensional fingerprinting (MDF) utilizes measurable peptide characteristics to identify proteins. In this study, 3‐D fingerprinting, namely, parent...”
-
8“...Intracerebral microdialysis was used to sample neurotransmitters from the extracellular fluid of the nucleus accumbens (NAS). Sample concentrations of dopamine...”
-
10“...1 2 23434 34 Light emitting compounds of the formula: where Ris a light-emitting moiety, Ris a bombesin-like peptide and fragment, derivative or analog thereof...”
-
11“...Light emitting compounds of the formula: where R1 is a light-emitting moiety, R2 is a bombesin-like peptide and fragment, derivative or analog thereof and L is...”
-
12“...Light emitting compounds of the formulawhere R1 is a light-emitting moiety, R2 is a CRF-related peptide and fragment, derivative or analog thereof and L is a...”
-
13“...This invention relates to peptide-based compounds having light-emitting moieties. Peptides may be chemically linked with detectable "labels" and used as...”
-
14“...Light emitting compounds of the formula:where R1 is a light-emitting moiety and R2 is a motilin peptide and fragment, derivative or analog thereof The peptide...”
-
15“...This invention relates to peptide-based compounds having light-emitting moieties. Peptides may be chemically linked with detectable "labels" and used as...”